NovaBay Pharmaceuticals (NBY)
(Delayed Data from AMEX)
$1.94 USD
-0.22 (-10.19%)
Updated Jul 25, 2024 04:00 PM ET
After-Market: $2.04 +0.10 (5.15%) 7:58 PM ET
3-Hold of 5 3
F Value A Growth A Momentum B VGM
Earnings News For NBY
-
NovaBay Pharmaceuticals Reports Preliminary Second Quarter 2024 Net Revenue of $2.4 Million
-
NovaBay Pharmaceuticals Reports First Quarter 2024 Financial Results
-
NovaBay Pharmaceuticals Reports Preliminary Eyecare and Wound Care Revenue Increased 13% for the First Quarter of 2024 on Lower Sales and Marketing Expenses
-
NovaBay Pharmaceuticals Reports 2023 Fourth Quarter and Full Year Financial Results
-
NovaBay Pharmaceuticals Reports Third Quarter 2023 Financial Results
-
NovaBay Pharmaceuticals Reports Second Quarter 2023 Financial Results
-
NovaBay Pharmaceuticals Reports First Quarter 2023 Financial Results
-
NovaBay Pharmaceuticals Reports 2022 Fourth Quarter and Full Year Financial Results
-
NovaBay Pharmaceuticals Reports Third Quarter 2022 Financial Results
-
Analysts Estimate NovaBay Pharmaceuticals (NBY) to Report a Decline in Earnings: What to Look Out for
-
Will NovaBay Pharmaceuticals (NBY) Report Negative Earnings Next Week? What You Should Know